You May be Entitled to Significant Compensation Talc and endometrial cancer. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement would pay $400 million to US state AGs. Talc And Endometrial Cancer .

Johnson & Johnson (JNJ.N) has set aside $400 million to resolve U.S. state consumer protection actions as part of its wider $8.9 billion deal to settle claims that its Baby Powder and other talc-based products cause cancer. Talc and endometrial cancer.

J&J affiliate LTL Management filed a bankruptcy plan in New Jersey late on Monday that outlines how the firm plans to pay different kinds of cancer victims as part of a bankruptcy settlement. Talc and endometrial cancer. J&J has said that its talc products are safe and don’t cause cancer. It is attempting for another time to settle more than 38,000 lawsuits filed in bankruptcy and stop new cases from arising in the future.
LTL’s bankruptcy plans would deposit $400 million to an additional trust to settle lawsuits filed with state attorneys general claiming that J&J violated laws against unfair business practices in the State of New York as well as consumer protection laws by misinforming consumers regarding the quality of its talc products.

Many states had initiated consumer protection cases against J&J prior to the first bankruptcy filing prevented those investigations from moving forward in 2021. Talc and endometrial cancer. New Mexico and Mississippi had already filed suits in the past against Johnson & Johnson before then and states like Arizona, Maryland, North Carolina, Texas and Washington had issued civil investigative demands or subpoenas, according to LTL’s court papers.

New Mexico and Mississippi have moved to dismiss LTL’s bankruptcy along with cancer sufferers and their counterparts from the U.S. Justice Department’s bankruptcy watchdog. They have argued that a profitable business like J&J is not eligible for bankruptcy protections meant for the struggling debtors.
LTL’s first attempt at resolving the bankruptcy lawsuits was dismissed after similar arguments. In the end, a U.S. appeals court ruled the LTL had not been in “financial trouble” and was not eligible for bankruptcy protection. Talc and endometrial cancer. LTL filed a second bankruptcy in just two hours following that dismissal, arguing that the second bankruptcy was different due to the fact that there was less money available and more backing for the settlement.

New Mexico and Mississippi said in their motion to dismiss that LTL’s renewed bankruptcy violates the law enforcement powers of the state by trying to unilaterally cap LTL’s liability to state consumer protection laws.

Talc And Endometrial Cancer

LTL’s recent filings also provided additional details about how the company would assess and settle cancer claims if the bankruptcy plan is approved.

The most significant payments under the settlement would be $500,000 to those diagnosed with mesothelioma that is terminal before age 45. Talc and endometrial cancer. The second payment would be $260,000 for people diagnosed with advanced ovarian cancer before age 45.

From there, the proposed settlement provides discounts based on the kind and severity of the cancer, the person’s age, history of using talc and other factors. Talc and endometrial cancer. For instance the case of a woman who used talc products weekly, had a family history of ovarian cancer and was diagnosed with the stage 2 ovarian cancer when she was 55 may be eligible for a $21,125 payout under the settlement plan.

Judge gives order to J&J and talc opponents participate in settlement talks.

Following another hearing in Johnson &Johnson’s attempt to implement a Texas Two-Step bankruptcy strategy to resolve talc litigation and federal bankruptcy judge Michael Kaplan has ordered the company as well as those who oppose the strategy to engage in settlement talks, Bloomberg reports.

In its second bankruptcy effort for LTL Management, a subsidiary created by J&J to settle claims – the company proposed a settlement of $8.9 billion. Talc and endometrial cancer. While a firm representing plaintiffs supports the deal, another group opposes the move.

The previous week, the opposition group, called”The Official Committee of Talc Claimants requested the bankruptcy court to dismiss the case saying that LTL cannot be regarded as financially distressed.

“The filing is an incredibly legal and ineffective attempt by a small number of law firms to try to prevent claimants from voting on the resolution plan, a plan the vast and growing majority of claimants favor,” J&J’s litigation chief Erik Haas, said in an announcement. Talc and endometrial cancer. “The law firms involved in these filings have interests in finance that do not align with, differ from and are in opposition to the interests of their clients. We’ll soon submit a response to the appellate court.”

Talc and endometrial cancer. Clay Thompson, a lawyer for MRHFM, which is home to more than mesothelioma clients who have sued J&J, said that the second bankruptcy attempt of J&J will fail.

“J&J sends out press releases describing how fantastic the plan is but simultaneously insisting that the plan’s details, including what the individual sick individuals would receive,” Thompson said in an email. “What do J&J have to cover up?”

Kaplan has commanded the parties to devise a second arrangement plan under the supervision by two mediators.

As of February 2022 Kaplan acknowledged J&J’s use of Chapter 11 to hasten a settlement that would relieve the company from the tens of thousands of claims concerning its talcum products.

However, in the month of January, a federal appeals court ruled against the decision, deciding that the company could not be considered in “financial difficulty.”

After J&J’s make an appeal before the U.S. Supreme Court was rejected at the end of April J&J filed for its second bankruptcy just two hours after. In response to that move, Kaplan froze the lawsuits for 60 days to decide whether to allow an additional bankruptcy.

J&J’s unstoppable profit machine sputters after $6.9B settlement charge for talc.

Through Two Chapter 11 attempts, J&J has gotten 19 months of which cases were put in limbo. Talc and endometrial cancer. J&J wants the claimants to vote on accepting their settlement. J&J requires 75% of the vote for the deal to pass.

In addition to the gang of talc lawyers who criticised the company’s bankruptcy play as well, the U.S. Trustee is an arm of the U.S. Department of Justice, also filed motions to dismiss LTL’s second bankruptcy.

In a recent filing, U.S. trustee Andrew R. Vara wrote that the doors of bankruptcy are “open to honest but unfortunate debtors.” The doors “are not open to parties that do not have a legitimate goal or who seek to use bankruptcy to hinder or delay their creditors,” Vara continued.

To its credit, J&J maintains there is no definitive evidence to suggest that its products containing talc, such as the famous baby powder, can cause cancer. J&J has taken its products off of the market–first for North America in 2020–and the rest of the world next year.

J&J intends to steer clear of the cost of going to court. It has prevailed in most of the cases that were decided in court, however some losses have been punitive.
A high-profile trial in Missouri led to an $4.7 billion verdict against the drugmaker, which was later reduced to $2.1 billion following appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
Overall, J&J has lost nine talc trials that are either in appeal or settled. Out of 41 trials 32 of them ended in the favor of J&J as well as mistrials or plaintiff verdicts that were reversed after appeal. Talc and endometrial cancer. Additionally, the company has announced plans to settle more than 1,000 cases for the sum of $100 million. Bloomberg announced at that time.

Talcum Baby Powder Ovarian Cancer Lawsuit – Talc And Endometrial Cancer

Our lawyers handle baby powder lawsuits across all 50 states. The lawsuits involving talcum powder on behalf of Johnson & Johnson have been ongoing for many years. Talc and endometrial cancer. The lawsuits allege that prolonged use of the powder (or “talc”), the active ingredient in many products, including the Baby Powder or Shower to Shower, can cause cancer of the ovary in certain women.

This page gives an J&J update on the talc power litigation and discusses how the upcoming bankruptcy ruling impacts the ultimate settlement amounts of these Ovarian Cancer lawsuits.

Is the deadline for you to make a claim for talcum powder? Many people who think the time limit has expired to sue Johnson & Johnson are wrong. Call us now at 800-553-2082 or get a no-cost, quick case review online.

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Talc And Endometrial Cancer

June 2 2023 Update: During the asbestos talc trial at the trial in California yesterday, a couple of technical issues interrupted the opening statement by the defense attorneys. Talc and endometrial cancer. The jurors, attending from their homes via Zoom however, heard Johnson & Johnson’s lawyer voice his doubt about the 70s research claiming asbestos was present in their product prior to the proceedings abruptly ended.

Meanwhile, the plaintiff had the opportunity to present the first of their witnesses, Arthur Langer. Langer stated that the presence of other minerals alongside talc is expected. He said that his team advised J&J in 1971 about the presence of chrysotile asbestos within the talc produced by the company, although at just 0.1 percent. The asbestos was discovered by him in 1976.

June 1st, 2023 Update Talc and endometrial cancer. First trial after J&J took the decision to disband its talc division and declare bankruptcy is a pivotal moment in the ongoing talc litigation controversy. Trial began yesterday in the harrowing case of a young 24 year-old plaintiff, diagnosed with a rare and aggressive form of mesothelioma last year, which lawyers on both sides agree is a grave tragedy.

Opening statements laid bare huge differences between the sides’ story. The plaintiff’s attorney took aim on Johnson & Johnson, alleging the use of misleading methods in their research practices as well as throughout the litigation procedure. The attorney claims that, according to, the company attempted to manipulate the definition of asbestos despite internal documents dating back to 1978 and 1994 showing that asbestos fibers found in tissue of the plaintiffs are included.

Johnson &J’s highly uncertain $8.9 billion settlement is hanging in the balance as we progression of this trial. Despite the unique nature of this mesothelioma-related case and its unique challenges compared to the majority of talcum powder lawsuits, a verdict favoring the plaintiff could inflict an unintended setback to Johnson & J’s hopes for broad acceptance of the settlement they have proposed among plaintiffs.

May 31st, 2023 Update: Johnson & Johnson’s bankrupt talc business vigorously defended it’s two-time Chapter 11 filing in the facing challenges from injured talc claimants. In an objection submitted to the New Jersey bankruptcy court, the subsidiary argued that the situation was vastly different from the previous filing. The subsidiary emphasized the record-breaking commitment of $8.9 billion in settlement from J&J which is the biggest settlement ever to be made in an bankruptcy case involving mass torts. Talc and endometrial cancer. The issue is not discussed: whether this amount implies that it is a fair settlement. J&J also claimed that it received support from a variety of plaintiffs’ law firms representing more than 600,00 claimants. This is not easy to confirm but is probably incorrect.

May 24 2023 Update: In the wake of Johnson &J Johnson’s bankruptcy filing, the very first trial regarding its cosmetic talc items allegedly that contain asbestos is scheduled to start jury selection on Monday in California at Alameda County Superior Court, an historically reliable location for plaintiffs. The plaintiff claims that his mesothelioma resulted from asbestos exposure resulting from J&J’s products which that the company has denied. The trial also involves six retailers who are accused of selling talc-containing products.

May 22nd, 2023 Update Lawyers involved in the second J&J talc bankruptcy are battling over who should be appointed to the position of future claims representative. This is an important role essential to the resolution of the claims involving talc. Talc and endometrial cancer. Randi Ellis, a lawyer who frequently appears in MDLs all over the nation was appointed the claims representative during the first bankruptcy. J&J’s defense attorneys want Ellis to be appointed to that role yet again, but the lawyers for the talc plaintiffs have raised objections to the claim that Ellis has an interest conflict that should prevent her from taking on that role for the second time. The conflict stems from the fact that Ellis was involved in the drafting of the highly disputable second bankruptcy, which raises concerns about her capability to remain neutral. In reality, this bankruptcy is likely to get dismissed anyway.

May 17th, 2023 Update: The pretend company J&J created to settle the talc litigation bankruptcy disclosed to an New Jersey bankruptcy court that they had allocated $400 million to settle the claims brought by states accusing J&J of misleading marketing for its talc products. Talc and endometrial cancer. So that makes it an $8.5 billion settlement for cancer victims. It is hard to imagine any scenario in which J&J can get these settlements for babies at these numbers. While J&J’s $8.5 billion offer seems like a lot of money initially, it will not look great when you consider the math. The proposed settlement based on our rough calculations, would not provide victims with much more than a median settlement of $100,000 per case. That’s not enough.

May 15th 2023 Update: J&J might be facing lawsuit brought by an advocacy group representing cancer victims. Talc and endometrial cancer. The group argues that J&J deliberately retracted a $61.5 billion fund-raising agreement that it had with its company subsidiary LTL Management LLC, to simulate financial distress and to validate the company’s Chapter 11 bankruptcy filing. The group claims this decision could be interpreted as a fraudulent transfer of the rights of victims’ compensation. They plan to explore J&J’s actions following of the decision to dismiss LTL’s first bankruptcy case.

May 10, 2023 Update: Next week, this week the U.S. Bankruptcy Court in New Jersey will hear oral arguments in a motion reject the second bankruptcy filing that was filed by J&J LTL Management, J&J’s subsidiary. LTL Management. In the meantime, however, LTL Management has filed an order which requires both sides to participate in a new settlement negotiation in the hope that it will be possible to reach a global settlement agreement come to fruition.

May 5th, 2023 Update: Talc producer Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to numerous lawsuits alleging its talc products cause cancer from asbestos exposure. Talc and endometrial cancer. Over 2700 people have sued the firm and the company was spending $1 million a month on legal defense. The company’s most recent $29 million verdict at the Supreme Court of South Carolina forced it to seek bankruptcy protection, arguing for equitable distribution of assets among talc claimants instead of being taken from the receiver. Other suppliers of talc have declared bankruptcy because of the litigation.

May 4, 2023 Update U.S. Court of Bankruptcy Michael Kaplan has directed Johnson & Johnson to restart settlement discussions with lawyers who rebuffed the proposed $8.9 billion agreement. The court in Trenton, New Jersey yesterday the parties appeared in court to discuss next steps for their second bankruptcy matter. Judge Kaplan has pushed for further settlement talks.

This is the solution to resolve the claims of J&J. A settlement for baby powder can be achieved. Talc and endometrial cancer. However, it will require additional money – perhaps billions of dollars – from Johnson & Johnson.

Lawyers are divided over whether or not to accept the plan and not every client views the issue the same way their attorney does. The second bankruptcy case is likely to fail, as Judge Kaplan has scheduled a hearing for June to determine whether to dismiss the bankruptcy for the second time.

May 3 2023 Update The group of cancer patients suing Johnson & Johnson (J&J) asked that the Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it is an attempt to derail the litigation surrounding talc-based products. The group representing claimants for talc has filed a motion this week, asking the Third Circuit to consider their case and then send it back an earlier court, with instructions to dismiss the bankruptcy. Talc and endometrial cancer. They also asked that stoppage of tort litigation against J&J should be permitted to continue.
LTL requested Chapter 11 protection once again following its bankruptcy filing that was denied by the Third Circuit earlier this year and offered the possibility of an $8.9 billion deal. The committee believes that the recent ruling allowing LTL’s 2nd Chapter 11 to continue, and also stopping trials against J&J and J&J, requires immediate Third Circuit review. The US Trustee also requested that an New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s global vice president of litigation, Erik Haas, was quoted by Bloomberg declaring that J&J plans to file a formal response to the appeals court calling the request an “desperate and legally flawed plan” by a handful of law firms with conflicting financial interests.
May 1, 2023 Update: One most frequently asked question is how plaintiffs and their attorneys turn around $8.9 billion. Of course, that is an enormous amount of money. There are a lot of victims. Talc and endometrial cancer. They are a great claims for plaintiffs. We were reminded recently in two talc trials which led to huge verdicts for plaintiffs. In February mesothelioma cases, a talcum powder trial in Oregon resulted in an award that was $18.1 million. A month later, another mesothelioma talc case was brought to trial within South Carolina and resulted in a verdict of $29million for the plaintiff. In both instances, the defendant was Whittaker, Clark & Daniels Inc., one of the most prominent suppliers of talc in the U.S.
April 30th 2023 Update: In the year 2023, when J&J first tried to bring the lawsuit over talcum powder into bankruptcy, it did so with an offer to reserve $2 billion for settlements. The sum was ridiculously low. None of the talc plaintiffs supported the offer. This time, however, J&J has increased the offer to $8.9 for talc-related plaintiffs if they accept a bankruptcy settlement and also has the support of a large section of the talc victims and their lawyers. Talc and endometrial cancer. However, 75% of talc plaintiffs, which is required for bankruptcy plan approval It’s a long and difficult process because of the number of lawyers who have huge stocks of baby powder litigations opposed against the proposed settlement.

What can be done to end the impasse? More billions.
April 25, 2023, Update Talc Cancer victims have sought a court order to disqualify their Chapter 11 case filed by LTL Management LLC, a absurdly fabricated Johnson & Johnson subsidiary, saying the company is not financially distressed. LTL requested Chapter 11 to settle tens of thousands of claims that J&J’s baby powders cause cancer. Talc and endometrial cancer. In the end, however, the 3rd Circuit dismissed its first Chapter 11 case in January The court ruled that the company was not eligible to receive bankruptcy relief because it failed to show financial distress.

The plaintiffs argue that the third Chapter 11 case is an misuse of the bankruptcy system and it is being pursued in bad good faith. J&J says the bankruptcy settlement has “significant backing” from companies representing about 60,000 potential plaintiffs. It is fair to say plaintiffs’ lawyers and victims ‘ lawyers are not united over what they believe is an $8.9 billion offer for settlement.

April 21st, 2023 Update A bankruptcy judge has ruled the company Johnson & Johnson must face new lawsuits claiming that the company sold a baby powder that contained a chemical that causes cancer. Although trials for Talc lawsuits are suspended for at least 60 days but new lawsuits can be filed, and lawyers can begin preparing their cases. Talc and endometrial cancer. The judge expressed skepticism over J&J’s pathetic attempt to revive its strategy with the second bankruptcy case.

April 13th 2023 update: the most important update is about the $8.9 billion over the next 25 year period settlement offered. Lawyers representing cancer victims in the MDL Class Action have promised to fight the settlement alongside those who claim talc. Why? They think it is not enough for those suffering from cancer who are 70,000. Talc and endometrial cancer. The lawyers say that J&J should negotiate a larger settlement or litigate individual claims if the most recent bankruptcy is thrown out.

However, there is a second group of lawyers that is not part of the leadership group in that class action. These lawyers have collectively amassed hundreds of thousands of cases. This group wants to settle the case now in what many believe to be less than the victims deserve. Their argument is two-fold. The first is that they claim the settlement of around an average of $100,000 per plaintiff – is fair.

That is a hard argument to make. However, their second argument has more force: victims should now not wait and they want the money immediately.

April 12, 2023 Update: People are looking for ways J&J could file for bankruptcy again. The answer is complicated and complicated. But let’s try to explain it in simple terms.
Johnson & Johnson asserts that bankruptcy is the only way to address both present and future talc-related lawsuits definitively. It believes that it will be less expensive if there is a bankruptcy element that creates pressure to settle. Talc and endometrial cancer. In a quest to cover the 400-year span of American past, the company believes that bankruptcy is beneficial to all parties because it distributes settlements more equally and effectively than trial courts which are where litigants get significant payouts, while others are left with nothing.

The gist of this 3rd Circuit decision was this is not a matter of an enterprise that is profitable, forming subsidiaries to meet the legal risk and declare bankruptcy – Congress contemplated when drafting the Bankruptcy Code. It also clarified it was not in financial distress because J&J promised unlimited funding.
Thus, J&J did not hesitate to take advantage of the unlimited funding part of the holding and didn’t make any promises to offer unlimited funding for litigation. The company claims that modified financing arrangements with its subsidiary address the appeals court’s concerns, while offering funds to pay claims. As if offering victims less money will solve the problem at hand.

Attorneys representing cancer patients who oppose the agreement counter this with what you conclude is countering legal nonsense legal nonsense: J&J fraudulently transferred $50 billion in assets to LTL Management to circumvent the appeals court’s earlier decision. Hyperbole is not exempt: victims’ lawyers call it the biggest “fraudulent move in United States history.”

Despite all the legal jargon, J&J does not really believe this bankruptcy will be able to last. But it’s a way of pushing this $8.9 billion settlement and keep pressure on plaintiffs.

April 10 2023 update: Bloomberg provides an insightful article about a new law within New Jersey that is shedding new light on the funding of litigation in the baby powder plaintiffs in the class action. Litigation funders Virage Capital Management and TRGP Capital invested in hundreds of lawsuits that were brought against Johnson & Johnson (J&J) regarding talc products, in exchange for a share of any settlements. J&J is now willing that it will pay $8.9 billion to settle any lawsuits.

The funders’ involvement is publicly available due to an New Jersey court rule requiring the disclosure of certain information about funders outside the state. This rule is intended to tackle the growing demands for regulation of the litigation funders. J&J has to deal with more than 60,000 lawsuits when you combine federal and state baby powder lawsuits. Third-party financing in mass tort cases has pros and pros and. There is no doubt that we are witnessing how third-party funding could level the playing field for individuals as well as large corporations in court.

April 4 2023 Update: It’s interesting to watch the worm turn in this lawsuit. J&J has taken another blow this week, when the Third Circuit denied J&J’s request to keep the automatic stay in place while J&J appeals an order granting bankruptcy to the U.S. Supreme Court. The automatic stay has stopped thousands of talcum powder cases and stopped new lawsuits from getting filed ever since J&J initiated the controversial effort to spin the talc liabilities off into a bankrupt subsidiary over a year earlier. Talc and endometrial cancer. After the 3rd Circuit ruled that this bankruptcy was insufficient a few months ago, the stay was removed. J&J wanted to see it continued pending hearing the SCOTUS appeal. The answer was no.
April 1st, 2023 Update Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. The odds that for the Supreme Court is willing even to consider the appeal? Low.
March 16th, 2023 Update: with the bankruptcy stay being officially lifted, the very first new cases were filed and incorporated into the Talcum Powder class action MDL within a year. Seven new talc lawsuits were brought into the MDL during the month of March and brought the total number of cases in the pending process up to 37,522.

February 25 2023 Update: A Congressmen from Tennessee is now requesting that The U.S. Government Accountability Office (GAO) begin an investigation to determine how much J&J Talc products have cost the government in the many years.
In a recent letter to the GAO, Rep. Steven Cohen (D-Ten.) claimed that J&J of ignoring the risks of its talc products for years while tax dollars were utilized to treat people injured by exposure to the products. The demand comes just weeks following J&J’s dramatic loss in the 3rd Circuit Court of Appeals.

Talc and endometrial cancer. J&J has to begin making reasonable settlements for victims in order getting this behind it. This is a disgrace to one of the greatest firms.

February 14 , 2023 Update: At an earlier hearing at the hearing in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention in light of the ruling of 3rd U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.

You May be Entitled to Significant Compensation Talc and endometrial cancer. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

>>> Talc And Endometrial Cancer